Medical Weight Loss for Elko, Nevada Residents
Elko, Nevada residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Elko through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Elko Residents Choose New Hope Weight Loss
New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, California that has treated over 5,400 patients since 2020. We serve Elko, Nevada through telehealth at some of the most transparent prices anywhere, semaglutide from $166/month and tirzepatide from $233/month · just $7.70/day. No insurance battles, no hidden fees. Care is overseen by Dr. Anjmun Sharma, M.D.
Elko is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.
In Elko, Nevada, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout downtown Elko and the greater Elko County area of northeastern Nevada. Every prescription for Elko is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
For Elko residents, being seen by video means starting this week instead of waiting for an in-person appointment. Compounded medication arrives in discreet, cold-pack packaging at your Elko address, usually within days.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Elko patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Elko
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Elko address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Elko
Does New Hope Weight Loss treat patients in Elko?
Yes. Although the clinic is in Costa Mesa, California, we treat Elko, Nevada residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Elko?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Elko address in cold-pack packaging.
What do Elko patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Elko do you serve?
We serve patients from across Elko by telehealth, including downtown Elko and the greater Elko County area of northeastern Nevada.
How soon can a Elko patient start treatment?
Most Elko patients complete the online intake in minutes and have Dr. Sharma's video review within about 48 hours. If you are a candidate and telehealth-eligible, medication ships shortly after, so many patients begin within roughly a week of starting.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Elko, Nevada by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.